LENSAR Q4 EPS $(0.12) Misses $(0.07) Estimate, Sales $16.025M Miss $20.300M Estimate
3/31/2026
Impact: -85
Healthcare
LENSAR (NASDAQ: LNSR) reported a Q4 loss of $(0.12) per share, missing the analyst estimate of $(0.07) by 71.43%. This represents a significant improvement from a loss of $(1.61) per share in the same quarter last year. The company's quarterly sales were $16.025 million, falling short of the $20.300 million estimate by 21.06% and reflecting a 4.22% decrease from $16.731 million in the previous year.
AI summary, not financial advice
Share: